PRF Technologies (PRFX) Common Equity (2019 - 2026)
PRF Technologies' (PRFX) quarterly Common Equity came in at $16.5 million in Q2 2026, up 13175.4% on a YoY basis from N/an in Q2 2025, and up 77.34% quarter-over-quarter from $9.3 million in Q4 2025.
Powered by 
Analysis
PRF Technologies (PRFX) Common Equity (2019 - 2026) Analysis & Trends
PRF Technologies (PRFX) has reported Common Equity for 8 consecutive years, with $16.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 13175.4% year-over-year to $16.5 million; the trailing twelve-month figure through Jun 2026 stood at $16.5 million (up 13175.4% YoY), and the FY2025 full-year result was $9.3 million, up 409.32% from the prior year.
- Common Equity climbed to $16.5 million in Q2 2026 per PRFX's latest filing, from $9.3 million in the prior quarter.
- Across five years, Common Equity topped out at $16.7 million in Q1 2022 and bottomed at -$2.0 million in Q2 2024.
- Historically, Common Equity has averaged $8.2 million across 5 years, with a median of $8.8 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Common Equity plunged 129.27% in 2024, then surged 13175.4% in 2026.
- Over 5 years, Common Equity stood at $11.0 million in 2022, then tumbled by 34.32% to $7.2 million in 2023, then tumbled by 74.8% to $1.8 million in 2024, then soared by 409.32% to $9.3 million in 2025, then surged by 77.34% to $16.5 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $16.5 million, $9.3 million, and -$126000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 7.76 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 14.26 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 4.08 Bn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 33.02 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | -1.77 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 597.21 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -191.48 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 768.16 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 42.44 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | 16.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.48 Mn |
| Dec 31, 2025 | 9.29 Mn |
| Jun 30, 2025 | -126,000.00 |
| Dec 31, 2024 | 1.82 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 7.24 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 6.97 Mn |
| Mar 31, 2023 | 8.89 Mn |
| Dec 31, 2022 | 11.02 Mn |
| Sep 30, 2022 | 13.42 Mn |
| Jun 30, 2022 | 15.20 Mn |
| Mar 31, 2022 | 16.70 Mn |
| Dec 31, 2021 | 18.08 Mn |
| Sep 30, 2021 | 19.48 Mn |
| Jun 30, 2021 | 19.01 Mn |
| Mar 31, 2021 | 20.40 Mn |
| Dec 31, 2020 | 16.62 Mn |
| Jun 30, 2020 | -14.16 Mn |
API Access
PRF Technologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();